$5.000
-0.020 (-0.40%)收盤時
TNON 資訊
TNON 事件
Tenon Medical Enters Agreement to Sell 597,610 Shares to Institutional Investor
WallachBeth Capital announced that on August 27, Tenon Medical has entered into a securities purchase agreement with an institutional investor to sell 597,610 shares of common stock, together with a warrant to purchase up to an aggregate 1,058,517 shares of common stock, in a private placement offering. The combined effective offering price for each share of common stock and accompanying warrants to be issued is $5.02. The combined effective offering price for each pre-funded warrant and accompanying warrants to be issued is $5.019. The pre-funded warrants will have an exercise price of $0.001 per share of common stock and the warrant will have an exercise price of $5.02 per share, will be immediately exercisable, and will expire five years from the date of issuance. The gross proceeds to the company from the offering are estimated to be approximately $3M before deducting the placement agent's fees and other estimated offering expenses. The offering is expected to close on or about August 31. WallachBeth Capital is acting as the sole placement agent in connection with the offering.
Tenon Medical Inc Trading Halted
Tenon Medical Inc trading halted, volatility trading pause
Tenon Medical Files $100M Mixed Securities Shelf
Tenon Medical files $100M mixed securities shelf
Tenon Medical Inc Trading Halted, News Pending
Tenon Medical Inc trading halted, news pending
Tenon Medical Receives FDA Clearance for Catamaran SI Joint Fusion System
Tenon Medical announced it has received U.S. Food and Drug Administration, FDA, 510(k) clearance for its Catamaran SI Joint Fusion System. The updated clearance incorporates various instrument upgrades, as well as the reclassification of certain instruments from disposable to reusable status. These enhancements are designed to further improve the performance of the Catamaran System while delivering meaningful economic benefits to the Company by eliminating ongoing per-procedure costs previously associated with disposable instrumentation.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。







